Full Text
Full text is available in PDF
Evaluation of the Relationship between Prostate Cancer and Serum ?nflammation Markers
Authors
1Department of Urology, Second Urology Clinic, Atatrk Teaching and Research Hospital, drmaldemir@yahoo.com.tr, Turkey
2Department of Urology, Second Urology Clinic, Atatrk Teaching and Research Hospital, Turkey
*Corresponding Author: Department of Urology, Second Urology Clinic, Atatrk Teaching and Research Hospital, drmaldemir@yahoo.com.tr, Turkey. Tel: +90-533-6309102. Fax: +90-312-2912705. Email: drmaldemir@yahoo.com.tr
Published online:Jan 31, 2010
Article type:Research Article
Received:Jul 16, 2009
Accepted:Jul 30, 2009
How to Cite:Aldemir M, Ener K, Dehni D, A?ras K, Kay?gil N. Evaluation of the Relationship between Prostate Cancer and Serum ?nflammation Markers. Nephro-Urol Mon. 2010;2(1):. doi:
Abstract
Background and Aims: In this study, we aimed to examine whether there is a relationship between the serum inflammation markers C-Reactive Protein (CRP), Lactate Dehydrogenase (LDH), erythrocyte sedimantation rate (ESR), ceruloplasmin; and stage of prostate cancer (Pca), serum prostate specific antigen (PSA) level and Gleason score in prostate cancer(Pca) patients.
Methods: Fourtyone patients diagnosed as prostate cancer, and 46 patients forming the control group, and diagnosed as benign prostatic hyperplasia (BPH) were included in this study. The prostate cancer group was divided into subgroups according to the following parameters; PSA ≤20 ng/mL and >20 ng/mL, Gleason scores of ≤6 and >6, and further the cases with and without bone metastasis.
Results: It was detected that serum levels of CRP, ceruloplasmin and ESR were significantly higher in prostate cancer group, compared with the control group (p<0,05). Serum levels of CRP, ceruloplasmin, LDH and ESR were significantly higher in the Pca group with Gleason score of >6 compared with the Pca patients Gleason score ≤6 (p<0.05). Also, CRP, ceruloplasmin, alkaline phosphatase(ALP), LDH and ESR were significantly higher in the patients with PSA>20 ng/mL, compared with the ones with serum PSA levels≤20 ng/mL in the Pca group, as well (p<0.05).
Conclusions: As a result, it is determined that, the serum inflammation markers are significantly higher at the patients with prostate cancer, especially for the ones with higher PSA and Gleason score.
Highlights
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
3
Sep
2024
Investigation of the Relationship Between Prostate-Specific Antigen Levels and Prostate Cancer in Patients Attending a Urology Clinic from 2014 to 2023
Hamed Mohseni Rad,
Ali Hosseinkhani,
Emad Hosseinkhani,
Mahdieh Aali
Mohseni Rad H, Hosseinkhani A, Hosseinkhani E, Aali M. Investigation of the Relationship Between Prostate-Specific Antigen Levels and Prostate Cancer in Patients Attending a Urology Clinic from 2014 to 2023. Nephro-Urol Mon. 2024;16(3):e147023. doi: https://doi.org/10.5812/numonthly-147023
30
Sep
2008
Evaluation of Preoperative Elevation of Serum C-Reactive Protein as an Indicator for Prognosis in Colorectal Cancer
Seyed Reza Mousavi,
M Talebianfar,
M Zeinalzadeh,
A Saberi,
A Kaviani,
M Aminseresht
,et al.Mousavi SR, Talebianfar M, Zeinalzadeh M, Saberi A, Kaviani A, et al. Evaluation of Preoperative Elevation of Serum C-Reactive Protein as an Indicator for Prognosis in Colorectal Cancer. Int J Cancer Manag. 2008;1(3):e80484. doi:
19
Jun
2004
A Comparative Study of Serum Prostate Specific Antigen Levels in Patients Suffering from Prostatic & Non-prostatic Cancers
H Kharrazi,
N Amiri Fard,
M Rezaei
Kharrazi H, Amiri Fard N, Rezaei M. A Comparative Study of Serum Prostate Specific Antigen Levels in Patients Suffering from Prostatic & Non-prostatic Cancers. J Kermanshah Univ Med Sci. 2004;8(2):e81329. doi:
15
Aug
2016
Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer
Mohammad Reza Nowroozi,
Seyed Ali Momeni,
Solmaz Ohadian Moghadam,
Elnaz Ayati,
Afshin Mortazavi,
Simin Arfae
,et al.Nowroozi MR, Momeni SA, Ohadian Moghadam S, Ayati E, Mortazavi A, et al. Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer. Nephro-Urol Mon. 2016;8(6):e39984. doi: https://doi.org/10.5812/numonthly.39984
7
Apr
2020
Serum and Urine Levels of Sarcosine in Benign Prostatic Hyperplasia and Newly Diagnosed Prostate Cancer Patients
Maral Yousefi,
Durdi Qujeq,
Hamid Shafi,
Karimollah Hajian Tilaki
Yousefi M, Qujeq D, Shafi H, Tilaki KH. Serum and Urine Levels of Sarcosine in Benign Prostatic Hyperplasia and Newly Diagnosed Prostate Cancer Patients. J Kermanshah Univ Med Sci. 2020;24(1):e97000. doi: https://doi.org/10.5812/jkums.97000
Cited by
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 0
Last Update: 0 months ago
- Scopus by Title (Ref): 4
Last Update: 0 months ago
- CrossRef: 0
Last Update: 3 days ago
- OpenAlex: 0
Last Update: 1 day ago
- OpenCitations: 0
Last Update: 14 hours ago
Comments
Number of Comments:0